JiangSu WuZhong Pharmaceutical Development Co Ltd
SSE:600200
Income Statement
Earnings Waterfall
JiangSu WuZhong Pharmaceutical Development Co Ltd
Revenue
|
2.1B
CNY
|
Cost of Revenue
|
-1.6B
CNY
|
Gross Profit
|
572.5m
CNY
|
Operating Expenses
|
-544.7m
CNY
|
Operating Income
|
27.8m
CNY
|
Other Expenses
|
-46.2m
CNY
|
Net Income
|
-18.4m
CNY
|
Income Statement
JiangSu WuZhong Pharmaceutical Development Co Ltd
Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
4 181
N/A
|
3 875
-7%
|
3 812
-2%
|
3 683
-3%
|
3 040
-17%
|
3 067
+1%
|
3 157
+3%
|
2 914
-8%
|
2 836
-3%
|
2 928
+3%
|
2 867
-2%
|
3 118
+9%
|
3 644
+17%
|
3 989
+9%
|
4 530
+14%
|
4 490
-1%
|
3 775
-16%
|
2 961
-22%
|
2 527
-15%
|
2 131
-16%
|
1 977
-7%
|
1 702
-14%
|
1 552
-9%
|
1 702
+10%
|
1 821
+7%
|
2 110
+16%
|
2 125
+1%
|
2 243
+6%
|
2 073
-8%
|
1 872
-10%
|
1 986
+6%
|
1 787
-10%
|
1 859
+4%
|
1 775
-4%
|
1 675
-6%
|
1 527
-9%
|
1 688
+11%
|
2 026
+20%
|
2 194
+8%
|
2 341
+7%
|
2 149
-8%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(3 783)
|
(3 415)
|
(3 341)
|
(3 185)
|
(2 557)
|
(2 615)
|
(2 698)
|
(2 510)
|
(2 444)
|
(2 594)
|
(2 578)
|
(2 820)
|
(3 332)
|
(3 555)
|
(4 073)
|
(3 973)
|
(3 171)
|
(2 323)
|
(1 845)
|
(1 445)
|
(1 339)
|
(1 099)
|
(1 011)
|
(1 142)
|
(1 240)
|
(1 487)
|
(1 521)
|
(1 682)
|
(1 527)
|
(1 300)
|
(1 440)
|
(1 232)
|
(1 320)
|
(1 270)
|
(1 157)
|
(1 018)
|
(1 165)
|
(1 448)
|
(1 624)
|
(1 740)
|
(1 577)
|
|
Gross Profit |
398
N/A
|
460
+16%
|
470
+2%
|
498
+6%
|
483
-3%
|
452
-6%
|
459
+2%
|
404
-12%
|
393
-3%
|
335
-15%
|
289
-14%
|
298
+3%
|
312
+5%
|
434
+39%
|
457
+5%
|
517
+13%
|
603
+17%
|
637
+6%
|
682
+7%
|
686
+1%
|
639
-7%
|
603
-6%
|
541
-10%
|
559
+3%
|
581
+4%
|
623
+7%
|
605
-3%
|
561
-7%
|
546
-3%
|
572
+5%
|
546
-5%
|
555
+2%
|
539
-3%
|
505
-6%
|
518
+3%
|
509
-2%
|
523
+3%
|
578
+11%
|
570
-1%
|
601
+6%
|
572
-5%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(266)
|
(282)
|
(271)
|
(280)
|
(295)
|
(273)
|
(274)
|
(272)
|
(265)
|
(295)
|
(268)
|
(260)
|
(278)
|
(356)
|
(350)
|
(391)
|
(449)
|
(509)
|
(566)
|
(587)
|
(595)
|
(636)
|
(962)
|
(1 005)
|
(1 066)
|
(613)
|
(613)
|
(602)
|
(552)
|
(952)
|
(987)
|
(981)
|
(968)
|
(529)
|
(535)
|
(528)
|
(541)
|
(595)
|
(587)
|
(585)
|
(545)
|
|
Selling, General & Administrative |
(250)
|
(264)
|
(266)
|
(272)
|
(286)
|
(250)
|
(268)
|
(269)
|
(263)
|
(264)
|
(272)
|
(267)
|
(286)
|
(318)
|
(348)
|
(394)
|
(436)
|
(452)
|
(557)
|
(576)
|
(596)
|
(584)
|
(571)
|
(604)
|
(668)
|
(615)
|
(605)
|
(593)
|
(544)
|
(623)
|
(617)
|
(608)
|
(599)
|
(514)
|
(522)
|
(519)
|
(521)
|
(559)
|
(567)
|
(562)
|
(519)
|
|
Research & Development |
0
|
(3)
|
0
|
0
|
0
|
(5)
|
0
|
0
|
0
|
(7)
|
0
|
0
|
0
|
(16)
|
0
|
0
|
(10)
|
(41)
|
0
|
0
|
(6)
|
(51)
|
(47)
|
(52)
|
(47)
|
(12)
|
(11)
|
(15)
|
(17)
|
(37)
|
(38)
|
(38)
|
(42)
|
(19)
|
(27)
|
(25)
|
(25)
|
(27)
|
(30)
|
(30)
|
(34)
|
|
Depreciation & Amortization |
0
|
(13)
|
0
|
0
|
0
|
(17)
|
0
|
0
|
0
|
(22)
|
0
|
0
|
0
|
(27)
|
0
|
0
|
0
|
(31)
|
0
|
0
|
0
|
(31)
|
0
|
0
|
0
|
(19)
|
0
|
0
|
0
|
(16)
|
0
|
0
|
0
|
(14)
|
0
|
0
|
0
|
(20)
|
0
|
0
|
0
|
|
Other Operating Expenses |
(16)
|
(2)
|
(5)
|
(7)
|
(8)
|
(2)
|
(6)
|
(3)
|
(2)
|
(2)
|
4
|
7
|
8
|
4
|
(2)
|
3
|
(3)
|
15
|
(9)
|
(11)
|
7
|
29
|
(345)
|
(349)
|
(351)
|
34
|
3
|
7
|
9
|
(276)
|
(332)
|
(335)
|
(327)
|
18
|
14
|
16
|
6
|
11
|
9
|
7
|
8
|
|
Operating Income |
132
N/A
|
179
+36%
|
200
+12%
|
218
+9%
|
189
-14%
|
179
-5%
|
185
+4%
|
132
-29%
|
128
-3%
|
40
-69%
|
20
-50%
|
37
+87%
|
34
-9%
|
78
+131%
|
107
+36%
|
126
+18%
|
154
+22%
|
128
-16%
|
116
-10%
|
100
-14%
|
44
-56%
|
(33)
N/A
|
(421)
-1 173%
|
(446)
-6%
|
(485)
-9%
|
10
N/A
|
(8)
N/A
|
(41)
-396%
|
(6)
+86%
|
(379)
-6 331%
|
(440)
-16%
|
(426)
+3%
|
(429)
-1%
|
(24)
+94%
|
(16)
+32%
|
(19)
-17%
|
(17)
+8%
|
(17)
+1%
|
(18)
-3%
|
16
N/A
|
28
+72%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(37)
|
(40)
|
(45)
|
(48)
|
(54)
|
(62)
|
(59)
|
(31)
|
(33)
|
31
|
30
|
7
|
17
|
(39)
|
(35)
|
(23)
|
(18)
|
44
|
57
|
117
|
171
|
210
|
216
|
206
|
216
|
10
|
113
|
49
|
(19)
|
(43)
|
(51)
|
(52)
|
(54)
|
(45)
|
(47)
|
(46)
|
(50)
|
(58)
|
(37)
|
(45)
|
(45)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
2
|
0
|
(2)
|
(2)
|
(367)
|
0
|
0
|
0
|
81
|
(0)
|
(0)
|
0
|
(58)
|
100
|
100
|
100
|
105
|
(1)
|
(1)
|
(1)
|
0
|
0
|
2
|
2
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
1
|
0
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
17
|
11
|
11
|
10
|
13
|
17
|
16
|
17
|
14
|
14
|
15
|
19
|
15
|
10
|
7
|
4
|
10
|
8
|
6
|
(4)
|
(13)
|
(32)
|
(30)
|
(24)
|
(35)
|
(23)
|
(29)
|
(17)
|
(7)
|
(21)
|
(14)
|
(23)
|
(16)
|
3
|
0
|
(1)
|
(0)
|
(0)
|
(2)
|
(1)
|
(2)
|
|
Pre-Tax Income |
112
N/A
|
150
+34%
|
166
+11%
|
181
+9%
|
147
-19%
|
133
-10%
|
142
+7%
|
117
-17%
|
108
-7%
|
85
-21%
|
66
-23%
|
63
-4%
|
66
+4%
|
48
-27%
|
78
+63%
|
106
+36%
|
144
+37%
|
184
+27%
|
179
-2%
|
212
+18%
|
201
-5%
|
(223)
N/A
|
(236)
-6%
|
(266)
-12%
|
(305)
-15%
|
77
N/A
|
76
-2%
|
(9)
N/A
|
(32)
-278%
|
(504)
-1 470%
|
(404)
+20%
|
(400)
+1%
|
(399)
+0%
|
39
N/A
|
(63)
N/A
|
(66)
-4%
|
(68)
-3%
|
(75)
-10%
|
(56)
+26%
|
(28)
+50%
|
(17)
+40%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(45)
|
(57)
|
(63)
|
(66)
|
(55)
|
(46)
|
(49)
|
(37)
|
(36)
|
(22)
|
(14)
|
(18)
|
31
|
30
|
28
|
25
|
(30)
|
(48)
|
(48)
|
(55)
|
(52)
|
(59)
|
(61)
|
(52)
|
(41)
|
(16)
|
(14)
|
(2)
|
(8)
|
(4)
|
(16)
|
(20)
|
(14)
|
(19)
|
(4)
|
(2)
|
(7)
|
(3)
|
(1)
|
(3)
|
(3)
|
|
Income from Continuing Operations |
67
|
93
|
103
|
114
|
92
|
87
|
93
|
80
|
73
|
63
|
52
|
45
|
96
|
78
|
106
|
131
|
115
|
135
|
132
|
157
|
149
|
(282)
|
(297)
|
(318)
|
(346)
|
62
|
62
|
(10)
|
(40)
|
(508)
|
(420)
|
(420)
|
(413)
|
21
|
(67)
|
(68)
|
(76)
|
(78)
|
(58)
|
(31)
|
(20)
|
|
Income to Minority Interest |
(14)
|
(43)
|
(52)
|
(64)
|
(47)
|
(46)
|
(58)
|
(38)
|
(34)
|
(14)
|
(7)
|
(9)
|
(7)
|
(6)
|
1
|
3
|
(2)
|
(2)
|
(3)
|
(5)
|
(3)
|
(3)
|
(2)
|
1
|
1
|
3
|
3
|
3
|
4
|
1
|
1
|
2
|
2
|
2
|
3
|
2
|
2
|
2
|
2
|
2
|
2
|
|
Net Income (Common) |
53
N/A
|
51
-4%
|
51
+0%
|
50
-1%
|
45
-11%
|
41
-9%
|
34
-16%
|
42
+21%
|
39
-7%
|
49
+27%
|
45
-8%
|
36
-21%
|
89
+149%
|
72
-19%
|
107
+48%
|
134
+26%
|
113
-16%
|
133
+17%
|
129
-3%
|
152
+18%
|
147
-3%
|
(286)
N/A
|
(299)
-5%
|
(317)
-6%
|
(345)
-9%
|
65
N/A
|
65
+0%
|
(7)
N/A
|
(37)
-420%
|
(506)
-1 272%
|
(419)
+17%
|
(418)
+0%
|
(411)
+2%
|
23
N/A
|
(65)
N/A
|
(66)
-3%
|
(73)
-11%
|
(76)
-4%
|
(56)
+27%
|
(29)
+47%
|
(18)
+37%
|
|
EPS (Diluted) |
0.09
N/A
|
0.08
-11%
|
0.09
+13%
|
0.09
N/A
|
0.08
-11%
|
0.07
-13%
|
0.06
-14%
|
0.07
+17%
|
0.07
N/A
|
0.07
N/A
|
0.08
+14%
|
0.06
-25%
|
0.13
+117%
|
0.11
-15%
|
0.16
+45%
|
0.2
+25%
|
0.17
-15%
|
0.18
+6%
|
0.18
N/A
|
0.21
+17%
|
0.2
-5%
|
-0.4
N/A
|
-0.42
-5%
|
-0.45
-7%
|
-0.49
-9%
|
0.09
N/A
|
0.08
-11%
|
-0.02
N/A
|
-0.06
-200%
|
-0.71
-1 083%
|
-0.58
+18%
|
-0.58
N/A
|
-0.56
+3%
|
0.03
N/A
|
-0.09
N/A
|
-0.1
-11%
|
-0.11
-10%
|
-0.11
N/A
|
-0.08
+27%
|
-0.04
+50%
|
-0.02
+50%
|